The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Abstract
To evaluate the safety and efficacy of the Port Delivery System with ranibizumab (PDS) for neovascular age-related macular degeneration (nAMD) treatment.Phase 2, multicenter, randomized, active treatment-controlled clinical trial.Patients diagnosed with nAMD within 9 months who had received 2 or more prior anti-vascular endothelial growth factor intravitreal injections and were responsive to treatment.Patients were randomized 3:3:3:2 to receive...
Paper Details
Title
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Published Date
Aug 1, 2019
Journal
Volume
126
Issue
8
Pages
1141 - 1154
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History